1. Home
  2. TSSI vs ATYR Comparison

TSSI vs ATYR Comparison

Compare TSSI & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSSI
  • ATYR
  • Stock Information
  • Founded
  • TSSI 2004
  • ATYR 2005
  • Country
  • TSSI United States
  • ATYR United States
  • Employees
  • TSSI N/A
  • ATYR N/A
  • Industry
  • TSSI Professional Services
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TSSI Consumer Discretionary
  • ATYR Health Care
  • Exchange
  • TSSI Nasdaq
  • ATYR Nasdaq
  • Market Cap
  • TSSI 353.7M
  • ATYR 290.6M
  • IPO Year
  • TSSI N/A
  • ATYR 2015
  • Fundamental
  • Price
  • TSSI $7.33
  • ATYR $3.30
  • Analyst Decision
  • TSSI
  • ATYR Strong Buy
  • Analyst Count
  • TSSI 0
  • ATYR 6
  • Target Price
  • TSSI N/A
  • ATYR $18.60
  • AVG Volume (30 Days)
  • TSSI 640.4K
  • ATYR 1.1M
  • Earning Date
  • TSSI 05-15-2025
  • ATYR 05-07-2025
  • Dividend Yield
  • TSSI N/A
  • ATYR N/A
  • EPS Growth
  • TSSI 7042.86
  • ATYR N/A
  • EPS
  • TSSI 0.24
  • ATYR N/A
  • Revenue
  • TSSI $148,144,000.00
  • ATYR N/A
  • Revenue This Year
  • TSSI N/A
  • ATYR $551.06
  • Revenue Next Year
  • TSSI N/A
  • ATYR $2,144.84
  • P/E Ratio
  • TSSI $30.67
  • ATYR N/A
  • Revenue Growth
  • TSSI 172.33
  • ATYR N/A
  • 52 Week Low
  • TSSI $0.88
  • ATYR $1.42
  • 52 Week High
  • TSSI $18.26
  • ATYR $4.66
  • Technical
  • Relative Strength Index (RSI)
  • TSSI N/A
  • ATYR 52.29
  • Support Level
  • TSSI N/A
  • ATYR $3.06
  • Resistance Level
  • TSSI N/A
  • ATYR $3.45
  • Average True Range (ATR)
  • TSSI 0.00
  • ATYR 0.24
  • MACD
  • TSSI 0.00
  • ATYR 0.01
  • Stochastic Oscillator
  • TSSI 0.00
  • ATYR 52.46

About TSSI TSS Inc. Common Stock

TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: facilities, and systems integration. It generates the majority of its revenue from Systems integration services. It generates revenue from the United States.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: